Prince Harry And Meghan 'Frustrated' Over Details Of 'Peace Talks' With Royal Family Leaking To The Public
A Royal source said the meeting is a "significant move" to repairing the broken relationship between father and son following years of estrangement.
Meanwhile, Prince Harry's chance of mending his strained ties with his brother is said to be a "different matter entirely," as he'll find it "much harder to repair."
Prince Harry And Meghan Markle 'Frustrated' Following 'Peace Summit' Leak
Harry and Meghan are said to be "frustrated" after details of a "peace summit" were inadvertently captured on camera.
It is no secret that the Duke and Duchess of Sussex are open to reconciling with the king, especially after he was diagnosed with cancer last year.
It's seemingly in that line that the Montecito-based royals' chief of communications, Meredith Maines, met up with the king's communications secretary, Tobyn Andreae, at the Royal Over-Seas League near Clarence House in London last week.
A source said the summit was only the "first step towards reconciliation between Harry and his father, but at least it is a step in the right direction."
"There's a long road ahead, but a channel of communication is now open for the first time in years. There was no formal agenda, just casual drinks. There were things both sides wanted to talk about," the insider explained.
Although the outcome of the "peace talks" remains under wraps, pictures showing the two sides enjoying drinks raised hopes they'll be able to squash the feud.
However, Harry and Meghan are seemingly unhappy with how things are unfolding already, because they don't think having details about the meeting in newspapers is a good start.
According to The Telegraph, sources close to Prince Harry claim the Sussexes were not responsible for leaking details of the meeting to the press.
The Secret Meeting Had The King's Blessings
It remains unknown if it was Harry or King Charles who specifically instigated the meeting; however, the British monarch supposedly backed the talks, with a source close to Charles hailing it as a "significant moment" that could repair the relationship with his son.
A source told The Mirror: "The King has consistently shown he loves both his sons and, as he has done in the past, is prepared to meet Harry when their diaries allow."
They continued, "It's not unusual for aides from different households to meet, especially when there is a new influx of staff starting, but this is a significant moment."
The insider added, "If there is a period of calm and reflection on the part of the duke, then there'll be a way forward for him to begin along the road of repairing his relationship with his father."
Prince Harry's Feud With King Charles
The feud between Harry and his father started after he and his wife dropped their royal roles and relocated abroad.
Shortly after that, Harry gave interviews and accused his stepmother, Queen Camilla, of leaking private information to the press to make herself look good.
He also accused members of the royal family of getting "into bed with the devil" to gain favorable tabloid coverage, particularly mentioning how Camilla did all to rehabilitate her public image following her longtime affair with his father.
"That made her dangerous because of the connections that she was forging within the British press," Harry told CBS. "There was an open willingness on both sides to trade information. And with a family built on hierarchy, and with her on the way to being queen consort, there was going to be people or bodies left in the street."
The Duke Called For Reconciliation After Losing His Legal Appeal Over His Downgraded Security In The UK
Despite his grievances over security, especially after losing his legal appeal in the UK, the Duke of Sussex had an interview with the BBC, where he shared that he still hopes for reconciliation.
Harry claimed at the time that the king had avoided contact because of the "security stuff."
"There have been so many disagreements between myself and some of my family," Harry admitted. "Of course, they will never forgive me for lots of things, but... there's no point in continuing to fight anymore."
The prince added, "Life is precious. I don't know how much longer my father has; he won't speak to me because of this security stuff. It would be nice to reconcile."
In response, Buckingham Palace issued a statement noting that the security concerns had been "repeatedly and meticulously" reviewed by the courts, each time reaching the same verdict.
"All of these issues have been examined repeatedly and meticulously by the courts, with the same conclusion reached on each occasion," they said.
Prince Harry's Relationship With Prince William Will Be Harder To Repair
Although Harry and his father have since grown distant, he has shown just how much he loves the monarch, as he made a frantic dash to the UK upon learning of his cancer diagnosis.
However, the same cannot be said about the Duke's relationship with his elder brother, Prince William.
An insider who spoke to the Daily Mail cautioned that repairing their relationship is a "different matter entirely and one which he will find much harder to repair."
In fact, it is rumored that Harry and Meghan could lose their royal titles when William becomes the king, as he has reportedly not gotten over the serious allegations they made against the royal family upon relocating to the U.S.
A source told Radar that Charles was "especially stung" by Harry calling him an "emotionally cold father" in his book, "Spare," but would rather not strip the Sussexes of their titles as he's "very concerned about his image and fears backlash from his subjects," a concern that William doesn't have.
"Behind the scenes, people are saying that the royals have quietly sanctioned the title removal โ if Harry and Meghan step out of line again," the source said.
"The removal would require an Act of Parliament, but those in the know say the palace has already called several secret meetings to discuss the possibility and put an actionable plan in place," they added.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Video: Modric greeted by huge crowd of AC Milan fans
Hundreds of Milan fans crowded in the street to see new signing Luka Modric, who threw his shirt down to the supporters. The midfielder held his presentation press conference this afternoon and you can read his comments here. After that, he was taken to the club's flagship store in Via Dante to meet the fans, and they turned up in their droves. They packed out the street below the window and sang the Croatian's name as they waited for him to pop his head out of the window. He held up his Number 14 jersey and threw out a few of them to the waiting crowd before stepping down to meet some of them in person, sign autographs and pose for selfies. Milan fans give Modric a memorable reception ๐๐ฎ๐ค๐. ๐๐จ๐๐ซ๐ข๐. ๐๐. ๐๐. ๐๐ข๐ฅ๐๐ง. ๐ฅ๐ดโซ๏ธ ๐ฅ Alberto Mangili per #milanpress โ (@MilanPress_it) August 4, 2025 ๐๐๐๐ก๐ข ๐๐ ๐๐ข๐๐๐ ๐ฃ๐๐ฅ ๐ ๐ข๐๐ฅ๐๐ ๐ดโซ Store del Milan preso d'assalto dai tifosi rossoneri per incontrare il campione croato โ (@MilanNewsit) August 4, 2025 #Modric14 โ Daniele Longo (@86_longo) August 4, 2025 ๐๐บ๐บ๐ฎ๐ด๐ถ๐ป๐ถ ๐ฎ ๐น๐ผ๐ฟ๐ผ ๐บ๐ผ๐ฑ๐ผ ๐๐๐ผ๐ฟ๐ถ๐ฐ๐ต๐ฒ: ๐๐๐ธ๐ฎ ๐ ๐ผ๐ฑ๐ฟ๐ถ๐ฐ ๐ถ๐ป๐ฐ๐ผ๐ป๐๐ฟ๐ฎ ๐ถ ๐๐ถ๐ณ๐ผ๐๐ถ ๐ฑ๐ฒ๐น ๐ ๐ถ๐น๐ฎ๐ป ๐ฒ ๐๐ฐ๐ฎ๐บ๐ฏ๐ถ๐ฎ ๐ณ๐ผ๐๐ผ ๐ฒ ๐ฎ๐๐๐ผ๐ด๐ฟ๐ฎ๐ณ๐ถ โค๏ธ๐ค ๐ฅ Alberto Mangili per #Milan #milanpress
Yahoo
5 minutes ago
- Yahoo
Starmer pays tribute after death of ex-Labour general secretary Tom Sawyer
Prime Minister Sir Keir Starmer has led tributes following the death of former Labour Party general secretary Lord Tom Sawyer. He said the former trade unionist's 'place in our party's history is assured' as one of the leading figures in the build-up to the 1997 general election success. Lord Sawyer had been one of the key figures in the New Labour era and was credited with helping to steer through the reforms to the party in the run-up to Tony Blair's landslide win. Sir Keir said: 'I am deeply sorry to hear of the death of Tom Sawyer. From the factory floor to the House of Lords, he was driven throughout his life by an unrelenting belief in the dignity of working people and opportunity for all. 'As a trade unionist, he drove that mission forward. As general secretary of the Labour Party, he was integral to delivering the victory in 1997 that transformed the nation. 'His place in our party's history is assured and his loss will be felt deeply by the many people who admired and loved him. 'My thoughts are with his family at this time.' Lord Sawyer served as Labour's general secretary from 1994 until 1998 when he stood down and was made a peer as Lord Sawyer of Darlington. Before becoming Labour's general secretary he served as deputy general secretary of the National Union of Public Employees and deputy general secretary of Unison. Labour's current general secretary Hollie Ridley said: 'Lord Tom Sawyer served the Labour Party and Labour movement with distinction. 'As general secretary, member of the National Executive Committee and as a trade unionist, he played a significant role in the transformation of our party from years in opposition before leading Labour through the 1997 landslide general election victory. 'Tom's legacy is the legacy of those great Labour governments that rebuilt Britain's public services, lifted millions out of poverty and delivered change to the lives of people throughout his beloved north east of England. 'On behalf of the whole Labour Party, I send my deepest condolences to his family, friends and all those who were close to him.'
Yahoo
36 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.